Risk guided blood pressure treatment for cardiovascular care
A new analysis of the 2025 American Heart Association guidelines is reshaping how clinicians approach blood pressure treatment in older adults, moving away from blanket thresholds and toward decisions grounded in each patient’s individual risk profile.
Us2.ai co-founder and senior consultant cardiologist Dr. Carolyn Lam was featured in The Epoch Times this week, speaking to the heart of this shift: that the art of good medicine lies in matching treatment intensity to the patient in front of you, not chasing a number.
For health systems and clinicians navigating increasingly complex patient populations, this is precisely the challenge Us2.ai was built to address, bringing AI-powered cardiac diagnostics to the point of care so that risk can be assessed with speed, accuracy, and the nuance that patients deserve.
